ODDB.org: Open Drug Database

Pfizer AG - Campto 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	53470	Sequence	03
Product name	Campto 300 mg/15 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description	Irinotecan
Introduction of Sequence	22.10.2007

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

Inactive agents	Dose
Acidum Hydrochloridum
Lactic Acid
Sorbitol	675 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
049	Durchstechflasche(n)	288.99	328.05	A	SL	Yes

2025	©ywesee GmbH